Microorganisms and methods for the biological production of ethylene glycol

Abstract

The invention provides genetically engineered microorganisms and methods for the biological production of ethylene glycol and precursors of ethylene glycol. In particular, the microorganism of the invention produces ethylene glycol or a precursor of ethylene glycol through one or more of 5,10-methylenetetrahydrofolate, oxaloacetate, citrate, malate, and glycine. The invention further provides compositions comprising ethylene glycol or polymers of ethylene glycol such as polyethylene terephthalate.

1 . A genetically engineered C1-fixing microorganism capable of producing ethylene glycol or a precursor of ethylene glycol from a gaseous substrate, wherein the microorganism comprises a nucleic acid encoding a heterologous enzyme selected from a glycolaldehyde dehydrogenase having the EC number 1.2.1.21, a lactaldehyde dehydrogenase having the EC number 1.2.1.22, a succinate-semialdehyde dehydrogenase having the EC number 1.2.1.24, a 2,5-dioxovalerate dehydrogenase having the EC number 1.2.1.26, a betaine-aldehyde dehydrogenase having the EC number 1.2.1.8, or an aldehyde ferredoxin oxidoreductase having the EC number 1.2.7.5. 
     
     
         2 . The microorganism of  claim 1 , wherein the microorganism produces ethylene glycol or the precursor of ethylene glycol through one or more intermediates selected from the group consisting of 5,10-methylenetetrahydrofolate, oxaloacetate, citrate, malate, and glycine. 
     
     
         3 . The microorganism of  claim 1 , wherein the microorganism comprises one or more of:
 i) a nucleic acid encoding a heterologous enzyme capable of converting oxaloacetate to citrate;   ii) a nucleic acid encoding a heterologous enzyme capable of converting glycine to glyoxylate;   iii) a nucleic acid encoding a heterologous enzyme capable of converting iso-citrate to glyoxylate; or   iv) a nucleic acid encoding a heterologous enzyme capable of converting glycolate to glycolaldehyde.   
     
     
         4 . The microorganism of  claim 3 , wherein:
 a. the heterologous enzyme capable of converting oxaloacetate to citrate is a citrate [Si]-synthase [2.3.3.1], an ATP citrate synthase [2.3.3.8]; or a citrate (Re)-synthase [2.3.3.3];   b. the heterologous enzyme capable of converting glycine to glyoxylate is an alanine-glyoxylate transaminase [2.6.1.44], a serine-glyoxylate transaminase [2.6.1.45], a serine-pyruvate transaminase [2.6.1.51], a glycine-oxaloacetate transaminase [2.6.1.35], a glycine transaminase [2.6.1.4], a glycine dehydrogenase [1.4.1.10], an alanine dehydrogenase [1.4.1.1], or a glycine dehydrogenase [1.4.2.1]; and/or   c. the heterologous enzyme capable of converting iso-citrate to glyoxylate is an isocitrate lyase [4.1.3.1].   
     
     
         5 . The microorganism of  claim 3 , wherein one or more of the heterologous enzymes are derived from a genus selected from the group consisting of  Bacillus, Clostridium, Escherichia, Gluconobacter, Hyphomicrobium, Lysinibacillus, Paenibacillus, Pseudomonas, Sedimenticola, Sporosarcina, Streptomyces, Thermithiobacillus, Thermotoga,  and  Zea.    
     
     
         6 . The microorganism of  claim 3 , wherein one or more of the heterologous enzymes are codon-optimized for expression in the microorganism. 
     
     
         7 . The microorganism of  claim 3 , wherein the microorganism further comprises one or more of a nucleic acid encoding: an enzyme capable of converting acetyl-CoA to pyruvate having the EC number 1.2.7.1; an enzyme capable of converting pyruvate to oxaloacetate having the EC number 6.4.1.1; an enzyme capable of converting pyruvate to malate having the EC number 1.1.1.37, 1.1.1.38, 1.1.1.39, 1.1.1.40, 1.1.1.82, 1.1.1.83, 1.1.1.84, 1.1.1.85, 1.1.1.299, or 1.1.5.4; an enzyme capable of converting pyruvate to phosphoenolpyruvate having the EC number 2.7.1.40 or 2.7.9.2; an enzyme capable of converting oxaloacetate to citryl-CoA having the EC number 4.1.3.34; an enzyme capable of converting citryl-CoA to citrate having the EC number 2.8.3.10; an enzyme capable of converting citrate to aconitate and aconitate to iso-citrate having the EC number 4.2.1.3; an enzyme capable of converting phosphoenolpyruvate to oxaloacetate having the EC number 4.1.1.49 or 4.1.1.32; an enzyme capable of converting phosphoenolpyruvate to 2-phospho-D-glycerate having the EC number 4.2.1.11; an enzyme capable of converting 2-phospho-D-glycerate to 3-phospho-D-glycerate having the EC number 5.4.2.11/12; an enzyme capable of converting 3-phospho-D-glycerate to 3-phosphonooxypyruvate having the EC number 1.1.1.95; an enzyme capable of converting 3-phosphonooxypyruvate to 3-phospho-L-serine having the EC number 2.6.1.52; an enzyme capable of converting 3-phospho-L-serine to serine having the EC number 3.1.3.3; an enzyme capable of converting serine to glycine having the EC number 2.1.2.1; an enzyme capable of converting 5,10-methylenetetrahydrofolate to glycine having the EC number 1.4.4.2, 1.81.4, or 2.1.2.10; an enzyme capable of converting serine to hydroxypyruvate having the EC number 2.6.1.51, 2.6.1.45, 1.4.1.1, 1.4.1.5, 1.4.1.7, 2.6.1.2, 2.6.1.15. 2.6.1.21, or 2.6.1.44; an enzyme capable of converting D-glycerate to hydroxypyruvate having the EC number 1.1.1.29 or 1.1.1.81; an enzyme capable of converting malate to glyoxylate having the EC number 2.3.3.9 or 4.1.3.1; an enzyme capable of converting glyoxylate to glycolate having the EC number 1.1.1.29, 1.1.1.26/79, or 1.1.99.14; an enzyme capable of converting hydroxypyruvate to glycolaldehyde having the EC number 4.1.1.40 or 4.1.1.1; and an enzyme capable of converting glycolaldehyde to ethylene glycol having the EC number 1.1.1.77, 1.1.1.1, 1.1.1.2, 1.1.1.72, 1.1.1.8, or 1.1.1.21. 
     
     
         8 . The microorganism of  claim 3 , wherein the microorganism overexpresses:
 i) the heterologous enzyme capable of converting oxaloacetate to citrate;   ii) the heterologous enzyme capable of converting glycine to glyoxylate; and/or   iii). the heterologous enzyme capable of converting glycolate to glycolaldehyde.   
     
     
         9 . The microorganism of  claim 5 , wherein the microorganism overexpresses:
 i) the enzyme capable of converting pyruvate to oxaloacetate having the EC number 6.4.1.1;   ii) the enzyme capable of converting citrate to aconitate and aconitate to iso-citrate having the EC number 4.2.1.3;   iii) the enzyme capable of converting phosphoenolpyruvate to oxaloacetate having the EC number 4.1.1.49 or 4.1.1.32;   iv) the enzyme capable of converting serine to glycine having the EC number 2.1.2.1;   v) the enzyme capable of converting 5,10-methylenetetrahydrofolate to glycine having the EC number 1.4.4.2, 1.81.4, or 2.1.2.10;   vi) the enzyme capable of converting glyoxylate to glycolate having the EC number 2.3.3.9; and/or   vii) the enzyme capable of converting glycolaldehyde to ethylene glycol having the EC number 1.1.1.77, 1.1.1.1, 1.1.1.2, 1.1.1.72, 1.1.1.8, or 1.1.1.21.   
     
     
         10 . The microorganism of  claim 1 , wherein the microorganism comprises a disruptive mutation in one or more of isocitrate dehydrogenase, glycerate dehydrogenase, glycolate dehydrogenase, glycerate dehydrogenase, glycolate dehydrogenase, aldehyde ferredoxin oxidoreductase, and aldehyde dehydrogenase. 
     
     
         11 . The microorganism of  claim 1 , wherein the microorganism is a member of a genus selected from the group consisting of  Acetobacterium, Alkalibaculum, Blautia, Butyribacterium, Clostridium, Eubacterium, Moorella, Oxobacter, Sporomusa,  and  Thermoanaerobacter.    
     
     
         12 . The microorganism of  claim 1 , wherein the microorganism is derived from a parental microorganism selected from the group consisting of  Acetobacterium woodii, Alkalibaculum bacchii, Blautia producta, Butyribacterium methylotrophicum, Clostridium aceticum, Clostridium autoethanogenum, Clostridium carboxidivorans, Clostridium coskatii, Clostridium drakei, Clostridium formicoaceticum, Clostridium ljungdahlii, Clostridium magnum, Clostridium ragsdalei, Clostridium scatologenes, Eubacterium limosum, Moorella thermautotrophica, Moorella thermoacetica, Oxobacter pfennigii, Sporomusa ovata, Sporomusa silvacetica, Sporomusa sphaeroides,  and  Thermoanaerobacter kiuvi.    
     
     
         13 . The microorganism of  claim 12 , wherein the microorganism is derived from a parental bacterium selected from the group consisting of  Clostridium autoethanogenum, Clostridium ljungdahlii,  and  Clostridium ragsdalei.    
     
     
         14 . The microorganism of  claim 1 , wherein the microorganism comprises a native or heterologous Wood-Ljungdahl pathway. 
     
     
         15 . The microorganism of  claim 1 , wherein the precursor of ethylene glycol is glyoxylate or glycolate. 
     
     
         16 . A method of producing ethylene glycol or a precursor of ethylene glycol comprising culturing the microorganism of  claim 1  in a nutrient medium in the presence of a gaseous substrate, whereby the microorganism produces ethylene glycol or the precursor of ethylene glycol. 
     
     
         17 . The method of  claim 16 , wherein the gaseous substrate comprises one or more of CO, CO 2 , and H 2 . 
     
     
         18 . The method of  claim 16 , wherein the precursor of ethylene glycol is glyoxylate or glycolate. 
     
     
         19 . The method of  claim 16 , further comprising separating ethylene glycol or the precursor of ethylene glycol from the nutrient medium. 
     
     
         20 . The method of  claim 16 , wherein the microorganism further produces one or more of ethanol, 2,3-butanediol, and succinate.